This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1974 Feb;80(2):249-59.

doi: 10.7326/0003-4819-80-2-249.

Adriamycin. A new anticancer drug with significant clinical activity

R H Blum, S K Carter

PMID: 4590654
DOI: 10.7326/0003-4819-80-2-249

Review

Adriamycin. A new anticancer drug with significant clinical activity

R H Blum et al. Ann Intern Med. 1974 Feb.

. 1974 Feb;80(2):249-59.

doi: 10.7326/0003-4819-80-2-249.

Authors

R H Blum, S K Carter

PMID: 4590654
DOI: 10.7326/0003-4819-80-2-249

No abstract available

PubMed Disclaimer

Similar articles

Adriamycin-a review.
Carter SK. Carter SK. J Natl Cancer Inst. 1975 Dec;55(6):1265-74. doi: 10.1093/jnci/55.6.1265. J Natl Cancer Inst. 1975. PMID: 1107570 No abstract available.
The current management of malignancy -- VI other solid tumors.
Panettiere FJ. Panettiere FJ. Alaska Med. 1977 Mar;19(2):19-25. Alaska Med. 1977. PMID: 326087 Review. No abstract available.
Cancer chemotherapy: its role in the treatment strategy of hematologic malignancies and solid tumors.
Clarysse A, Kenis Y, Mathe G. Clarysse A, et al. Recent Results Cancer Res. 1976;(53):1-552. Recent Results Cancer Res. 1976. PMID: 189368 No abstract available.
Clinical cancer chemotherapy aimed at potential cell regulators.
Knock FE, Galt RM, Renaud OV, Oester YT. Knock FE, et al. Arch Surg. 1970 Feb;100(2):167-72. doi: 10.1001/archsurg.1970.01340200055013. Arch Surg. 1970. PMID: 5460788 No abstract available.
The present status of cancer chemotherapy.
Krakoff IH. Krakoff IH. Med Clin North Am. 1971 May;55(3):683-701. doi: 10.1016/s0025-7125(16)32511-1. Med Clin North Am. 1971. PMID: 4102661 Review. No abstract available.

See all similar articles

Cited by

Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity.
Jensen BC, McLeod HL. Jensen BC, et al. Pharmacogenomics. 2013 Jan;14(2):205-13. doi: 10.2217/pgs.12.205. Pharmacogenomics. 2013. PMID: 23327580 Free PMC article. Review.
Modified administration schedule of adriamycin in solid tumors.
Kolarić K, Maricić Z, Nola P, Krusić J. Kolarić K, et al. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1977;88(3):255-60. doi: 10.1007/BF00305363. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1977. PMID: 140542
Antiproliferative and cell apoptosis-inducing activities of compounds from Buddleja davidii in Mgc-803 cells.
Wu J, Yi W, Jin L, Hu D, Song B. Wu J, et al. Cell Div. 2012 Aug 31;7(1):20. doi: 10.1186/1747-1028-7-20. Cell Div. 2012. PMID: 22938042 Free PMC article.
Pharmacokinetics and disposition of 4'-O-tetrahydropyranyladriamycin in mice by HPLC analysis.
Iguchi H, Tone H, Ishikura T, Takeuchi T, Umezawa H. Iguchi H, et al. Cancer Chemother Pharmacol. 1985;15(2):132-40. doi: 10.1007/BF00257523. Cancer Chemother Pharmacol. 1985. PMID: 4017162
PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation.
Zhu S, Hong M, Zhang L, Tang G, Jiang Y, Pei Y. Zhu S, et al. Pharm Res. 2010 Jan;27(1):161-74. doi: 10.1007/s11095-009-9992-1. Epub 2009 Oct 28. Pharm Res. 2010. PMID: 19862607

See all "Cited by" articles

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database